Development of a Validated Stability-Indicating RP-HPLC Method for Dronedarone Hydrochloride in Pharmaceutical Formulation | OMICS International | Abstract
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Development of a Validated Stability-Indicating RP-HPLC Method for Dronedarone Hydrochloride in Pharmaceutical Formulation

Bhatt KK, Emanual Michael Patelia* and Ishani Amin

Department of Pharmaceutical Chemistry and Analysis, Indukaka Ipcowala College of Pharmacy, Gujarat, India

*Corresponding Author:
Emanual Michael Patelia
Department of Pharmaceutical Chemistry and Analysis
Indukaka Ipcowala College of Pharmacy
New Vallabh Vidyanagar–388121, Gujarat, India
E-mail: [email protected]

Received date: January 15, 2013; Accepted date: January 28, 2013; Published date: February 04, 2013

Citation: Bhatt KK, Patelia EM, Amin I (2013) Development of a Validated Stability- Indicating RP-HPLC Method for Dronedarone Hydrochloride in Pharmaceutical Formulation. J Anal Bioanal Tech 4:161. doi: 10.4172/2155-9872.1000161

Copyright: © 2013 Bhatt KK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


A simple, precise, rapid, selective, and economic reversed phase high-performance liquid chromatography (RPHPLC) method has been established for estimation analysis of DRO. A Brownlee ODS C-18 column (250×4.6 mm i.d) chromatographic column equilibrated with mobile phase methanol-0.02 M KH2PO4 (80:20, v/v) (Final pH adjusted to 4 using Orthophosphoric acid) was used. Mobile phase flow rate was maintained at 1 ml/min and effluents were monitored at 289 nm. The sample was injected using a 20 μl fixed loop, and the total run time was 10 min. Experimental conditions such as pH of mobile phase, column saturation time, selection of wavelength, etc. were critically studied and the optimum conditions were selected. In RP-HPLC linear range was found to be 5-15 μg/ml and, mean recovery was found to be 99.99-100.03% and Rt of dronedarone was found to be 4.7 min. Degradation in acid, base, peroxide and thermal was found in range 8-20%. This stability indicating HPLC method is economic, sensitive, and less time consuming than other chromatographic procedures. It is a user-friendly and importance tool for analysis of dronedarone in tablet dosage forms.